Patents by Inventor Karim BRANDT

Karim BRANDT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides And Use Thereof For Diagnosing And Treating Antiphospholipid Syndrome
    Publication number: 20240116994
    Abstract: The invention provides an isolated peptide and a peptide construct of formula I that binds antiphospholipid antibodies (aPLA). The present invention further provides methods for detection of aPLA. The present invention also provides methods for diagnosing and treating the antiphospholipid syndrome (APS).
    Type: Application
    Filed: March 17, 2022
    Publication date: April 11, 2024
    Inventors: Karim BRANDT, Francois MACH, Marc Casra MOGHBEL
  • Beta-2-glycoprotein 1 derived peptide and use thereof for treating antiphospholipid syndrome
    Patent number: 11919939
    Abstract: The invention provides an isolated peptide containing a motif that binds antiphospholipid antibodies (aPLA) and that is recognized by CD4+ T cells that are able to induce production of antiphospholipid antibodies (aPLA). The present invention further provides methods for detection of aPLA and CD4+ T cells able to induce production of aPLA. The present invention also provides methods for treating the antiphospholipid syndrome (APS).
    Type: Grant
    Filed: May 23, 2018
    Date of Patent: March 5, 2024
    Assignee: Université de Genève
    Inventor: Karim Brandt
  • BETA-2-GLYCOPROTEIN 1 DERIVED PEPTIDE AND USE THEREOF FOR TREATING ANTIPHOSPHOLIPID SYNDROME
    Publication number: 20200172596
    Abstract: The invention provides an isolated peptide containing a motif that binds antiphospholipid antibodies (aPLA) and that is recognized by CD4+ T cells that are able to induce production of antiphospholipid antibodies (aPLA). The present invention further provides methods for detection of aPLA and CD4+ T cells able to induce production of aPLA. The present invention also provides methods for treating the antiphospholipid syndrome (APS).
    Type: Application
    Filed: May 23, 2018
    Publication date: June 4, 2020
    Inventor: Karim BRANDT